Metraipolis › archive › dc_d854d09b73da

Eculizumab and ravulizumab clinical trial and real-world pharmacovigilance of meningococcal infections across indications — Europe PMC PMID:40938812

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40938812
DOI
10.1371/journal.pone.0332073
License (as archived)
solo-consultazione
Archived
2026-11-09T23:42:16.216Z
SHA-256 of the archived text
d88298b67dd7cda485ed0cd162f01f9311a6c139f7192f6deed059f8728596d8
Stable URL of this page
https://metraipolis.com/documento/dc_d854d09b73da

How to cite

Eculizumab and ravulizumab clinical trial and real-world pharmacovigilance of meningococcal infections across indications — Europe PMC PMID:40938812 — Europe PMC (en), https://europepmc.org/article/MED/40938812 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d854d09b73da (Metraipolis archive dc_d854d09b73da, sha256 d88298b67dd7cda485ed0cd162f01f9311a6c139f7192f6deed059f8728596d8)
BibTeX
@misc{dcd854d09b73da,
  title = {Eculizumab and ravulizumab clinical trial and real-world pharmacovigilance of meningococcal infections across indications — Europe PMC PMID:40938812},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40938812},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d854d09b73da; sha256 d88298b67dd7cda485ed0cd162f01f9311a6c139f7192f6deed059f8728596d8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40938812. Agents can read the archived copy with the MCP tool read_document.